Hyperglycaemia Attenuates Erythromycin-Induced Acceleration of Solid-Phase Gastric Emptying in Idiopathic and Diabetic Gastroparesis
- 1 January 1999
- journal article
- clinical trial
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 34 (4), 396-403
- https://doi.org/10.1080/003655299750026416
Abstract
Erythromycin has recently been found to be a gastrointestinal prokinetic agent in humans. Acute hyperglycaemia has been associated with delayed gastric emptying in both healthy controls and diabetic patients. Our aim was to investigate in gastroparetic patients (diabetics and idiopathics) whether hyperglycaemia, per se, reduces gastric motility during erythromycin-induced acceleration of gastric emptying of solids. In 12 gastroparetic patients, 6 diabetics and 6 idiopathics, gastric emptying of solids was measured scintigraphically after giving placebo in normoglycaemia (5-8.9 mmol/l glucose) or 200 mg erythromycin lactobionate intravenously in normo- or hyperglycaemia (16-19 mmol/l glucose) induced by intravenous glucose infusion in random order on separate days. Erythromycin in normoglycaemia accelerated solids gastric emptying compared with placebo in all patients by abolishing the lag-phase duration and by decreasing the retained percentage of a meal in the stomach at 120 and 150 min (14.5% +/- 5.3% versus 88.4% +/- 10.6% and 3.5% +/- 2.1% versus 70.1% +/- 15.4%, respectively) (P < 0.001). The retained isotopic percentage in the stomach after erythromycin in induced hyperglycaemia compared with erythromycin in normoglycaemia, at 120 and 150 min, was increased (51.9% +/- 9.8% versus 14.5% +/- 5.3%, and 24.5% +/- 5.9% versus 3.5% +/- 2.1%, respectively) (P < 0.001) but was decreased in comparison with placebo (P < 0.001). A significantly increased percentage of isotope was retained in the stomach of the diabetic patients at 120 and 150 min, compared with the idiopathics, only after giving erythromycin in the hyperglycaemic condition (57.6% +/- 8.7% versus 46.1% +/- 7.6% (P = 0.036) and 27.8% +/- 5.7% versus 21.1 +/- 4.4% (P = 0.040), respectively). Hyperglycaemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis and increases the retained isotopic meal in the stomach. Hyperglycaemia reduces gastric motility more in the diabetic patients with gastroparesis than in idiopathic patients.Keywords
This publication has 16 references indexed in Scilit:
- Highly variable gastric emptying in patients with insulin dependent diabetes mellitus.Gut, 1995
- Hyperglycaemia slows gastric emptying in Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1990
- Gastric and oesophageal emptying in patients with Type 2 (non-insulin-dependent) diabetes mellitusDiabetologia, 1989
- Erythromycin and its derivatives with motilin-like biological activities inhibit the specific binding of 125I-motilin to duodenal muscleBiochemical and Biophysical Research Communications, 1988
- Gastric and oesophageal emptying in insulin‐dependent diabetes mellitusJournal of Gastroenterology and Hepatology, 1986
- Definition of a gastric emptying abnormality in patients with anorexia nervosaDigestive Diseases and Sciences, 1985
- Abnormal intestinal motility in diabetics with the gastroparesis syndromeEuropean Journal of Clinical Investigation, 1984
- Disorders of Gastrointestinal Motility Associated with Diabetes MellitusAnnals of Internal Medicine, 1983
- Gastric emptying in diabetic autonomic neuropathy.Gut, 1977
- ASYMPTOMATIC GASTRIC RETENTION IN DIABETICS (GASTROPARESIS DIABETICORUM)Annals of Internal Medicine, 1958